These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31177904)

  • 21. Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latter.
    Lakhal K; Blel Y; Fysekidis M; Mohammedi K; Bouadma L
    Anaesthesia; 2008 Aug; 63(8):876-9. PubMed ID: 18518867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
    Belleville G; Morin CM
    Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
    Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
    BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced neuromuscular blockade and myasthenia gravis.
    Barrons RW
    Pharmacotherapy; 1997; 17(6):1220-32. PubMed ID: 9399604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients?
    Fleming L; Randell K; Harvey CJ; Espie CA
    Psychooncology; 2014 Jun; 23(6):679-84. PubMed ID: 24458543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute respiratory insufficiency revealing myasthenia gravis: apropos of 3 cases].
    Vodoff MV; Cremer R; Martinot A; Cuvellier JC; Fourier C; Hue V; Nuyts JP; Leclerc F
    Arch Pediatr; 1997 Sep; 4(9):845-8. PubMed ID: 9345565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment.
    Kulaksizoglu IB
    CNS Drugs; 2007; 21(6):473-81. PubMed ID: 17521227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac involvement in myasthenia gravis--is there a specific pattern?
    Călin C; Savu O; Dumitru D; Ghiorghiu I; Călin A; Capraru C; Popescu BA; Croitoru M; Vîlciu C; Ginghină C
    Rom J Intern Med; 2009; 47(2):179-89. PubMed ID: 20067169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myasthenia gravis and pregnancy: review of the literature and report of 2 cases].
    Cecatti JG; Pereira RI; Vial JS; Barini R
    Rev Paul Med; 1991; 109(1):41-6. PubMed ID: 1882173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia gravis and upper airway obstruction.
    Putman MT; Wise RA
    Chest; 1996 Feb; 109(2):400-4. PubMed ID: 8620712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiety sensitivity and sleep disturbance: Investigating associations among patients with co-occurring anxiety and substance use disorders.
    Dixon LJ; Lee AA; Gratz KL; Tull MT
    J Anxiety Disord; 2018 Jan; 53():9-15. PubMed ID: 29127882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of coeliac disease and myasthenia gravis].
    Csaplár M; Juhász M; Muzes G; Jakab C; Arányi Z; Rózsa C; Molnár B; Komoly S; Pápay J; Zágoni T; Herszényi L; Tulassay Z
    Orv Hetil; 2006 May; 147(18):841-4. PubMed ID: 16784139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular myasthenia gravis.
    Elrod RD; Weinberg DA
    Ophthalmol Clin North Am; 2004 Sep; 17(3):275-309; v. PubMed ID: 15337189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995).
    Dewey CW; Bailey CS; Shelton GD; Kass PH; Cardinet GH
    J Vet Intern Med; 1997; 11(2):50-7. PubMed ID: 9127290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution.
    Al-Hashel JY; Ismail II; John JK; Ibrahim M; Ali M
    Neuromuscul Disord; 2016; 26(4-5):309-11. PubMed ID: 27012182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tongue force in patients with myasthenia gravis.
    Weijnen FG; Kuks JB; van der Bilt A; van der Glas HW; Wassenberg MW; Bosman F
    Acta Neurol Scand; 2000 Nov; 102(5):303-8. PubMed ID: 11083507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myasthenia gravis.
    Pourmand R
    Dis Mon; 1997 Feb; 43(2):65-109. PubMed ID: 9118787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.